Successful treatment of the dupilumab-induced psoriatic dermatitis/arthritis and atopic dermatitis with a JAK inhibitor: A case report and literature review

Successful treatment of the dupilumab-induced psoriatic dermatitis/arthritis and atopic dermatitis with a JAK inhibitor: A case report and literature review

Dupilumab-induced psoriatic dermatitis and arthritis in a patient with atopic dermatitis were effectively managed with upadacitinib, highlighting the use of Janus kinase inhibitors as a possible treatment for biologic therapy side effects.

Saved in:
Bibliographic Details
Main Authors: Misuzu Tsunoda, MD, Takeya Adachi, MD, PhD, Yuuri Nakajima, MD, Yoshihiro Yatomi, MD, Tomoko Shimizu, MD, PhD, Katsuki Nakasute, MD
Format: Article
Language:English
Published: Elsevier 2024-11-01
Series:Journal of Allergy and Clinical Immunology: Global
Subjects:
Dupilumab
psoriasis
psoriatic arthritis
atopic disease
upadacitinib
Online Access:http://www.sciencedirect.com/science/article/pii/S277282932400119X
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S277282932400119X

Similar Items